Expensive biomedical equipment

Artificial heart has been officially approved for listing, and it is called "the jewel in the crown of medical devices". This is because the innovation and development of artificial heart means that the development of medical career has been upgraded to a higher level. More importantly, this artificial heart can save more young lives, and it is a more convenient, safer and longer-lived medical technology for heart transplantation.

The main function of artificial heart is to use biomechanical means to partially or completely replace the pumping function of the heart and maintain the blood circulation of patients. For patients with severe heart failure, artificial heart is an effective treatment method to replace heart transplantation. In the foreseeable future, the importance of artificial heart equipment will continue to rise. With the improvement of technology and the further decline of product prices, the global market is expected to continue to maintain rapid growth. It is expected that innovative enterprises in China will participate in the R&D competition of artificial heart in the future.

Hu Shengshou, academician of China Academy of Engineering and dean of Fuwai Hospital of China Academy of Medical Sciences, said that heart failure is the only heart disease with an increasing trend in the world. "Heart failure can be said to be a cancer in heart disease." However, the long-term effect of medical drugs for end-stage heart failure is not good, and the 5-year survival rate of patients with heart failure is only 35%. Therefore, patients can only recover through heart transplantation or artificial heart installation, but artificial heart has overcome the problem of insufficient transplant donors and has become the "main battlefield" for heart failure treatment.

This topic has attracted the attention of netizens, because it is, after all, a feat of the development of China's medical industry. If the artificial heart can work well and the price is reasonable, it will benefit the people.